- Supported exchanges /
- NASDAQ /
- RVPHW.NASDAQ
Reviva Pharmaceuticals Holdings Inc (RVPHW NASDAQ) stock market data APIs
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of various neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention"deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis; in clinical development respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis; and in preclinical development for the treatment of psoriasis. It is also developing RP1208 for the treatment of depression and obesity. Reviva Pharmaceuticals Holdings, Inc. was founded in 2018 and is headquartered in Cupertino, California.
Reviva Pharmaceuticals Holdings Inc Financial Data Overview
| 0.13 | |
| 0.18 | |
| - | |
| 0.1925 | |
| 0.1201 | |
| 0.0737-1.78 | |
| 85 814 K | |
| 0 | |
| 0 | |
| -0.102 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Reviva Pharmaceuticals Holdings Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -1 949 024
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Reviva Pharmaceuticals Holdings Inc Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get Reviva Pharmaceuticals Holdings Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
